Pure Global AI
Liechtenstein flag

Liechtenstein medical device registration timeline

Source-linked clocks

Office of Public Health (Office of Public Health) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — EU MDR (EEA) classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-08-29eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))
MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock
0 days6-9 months—Verified
Review clocks exclude applicant hold time · planning totals are estimates

Planning steps and estimates; these are not regulator deadlines.

Liechtenstein Medical Device Registration Process

Step-by-step Office of Public Health registration process. Total estimated timeline: 6-9 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by Office of Public Health. Appoint a EU Authorized Representative.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to Office of Public Health including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

Office of Public Health reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. Office of Public Health may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, Office of Public Health issues Liechtenstein market authorization certificate.

Summary: The Liechtenstein medical device registration process through Office of Public Health (Office of Public Health) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
FDA 510(k)/PMANo substitute for EU MDR conformity assessment; useful as predicate documentation in the technical file
Key requirements
  • EU/EEA Authorized Representative (for non-EEA manufacturers)
  • Liechtenstein applies the EU MDR directly as an EEA member (Medical Devices Ordinance)
  • Clinical investigation: 45-day authorisation (+20 with experts) per MDR Art. 70(6) as applied in the EEA
  • Art. 74(1) PMCF investigations notified at least 30 days before start
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the Liechtenstein resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against Office of Public Health publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:liechtenstein:class-i